SGLT2 Inhibitors in Heart Failure: Underused Even Among Cardiologists?
A Missed Opportunity: SGLT2 inhibitors in Heart Failure Care Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have transformed heart failure management, reducing both hospitalizations and cardiovascular deaths across the ejection fraction spectrum. Guidelines now recommend SGLT2i as foundational therapy for patients with heart failure—yet real-world prescribing still lags far behind. A new retrospective cohort study of over […]
SGLT2 Inhibitors in Heart Failure: Underused Even Among Cardiologists? Read More »